Strykagen - Crunchbase Company Profile & Funding

Q: Where is Strykagen's headquarters?

Strykagen is located in Reno, Nevada, United States.

Q: Who invested in Strykagen?

Strykagen is funded by National Institutes of Health.

Q: When was the last funding round for Strykagen?

Strykagen closed its last funding round on obfuscated from a Grant round.

Q: How much funding has Strykagen raised to date?

Strykagen has raised obfuscated.

Overview

Strykagen

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Strykagen

CB Rank

120908

Strykagen manufactures transforming diagnostics and therapeutics for life-threatening rare muscle diseases.

Founded

obfuscation

Private

Grant

Reno, Nevada, United States

1-10

www.strykagen.com/

Biotechnology

Health Care

Manufacturing

Medical

Therapeutics

Funding Rounds

Grant

OBF

obfuscation

Key People

Dean J. Burkin: Founder and CEO
Ryan Wuebbles: Co-Founder and CSO

Details

Legal Name

Strykagen Corporation

Operating Status

Active

Company Type

For Profit

Founders

David A. Maine, Dean J. Burkin, Ryan Wuebbles

Contact Email

strykagen@gmail.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Integrin Therapeutics

Therapeutics targeting the α7β1 integrin to modify and slow progression of muscular dystrophies by enhancing muscle cell adhesion.

Small Molecule Therapeutics (Strykagen-969)

Orally deliverable small molecule that increases α7β1 integrin levels in muscle cells to improve muscle strength in muscular dystrophy models.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Strykagen	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Strykagen	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Strykagen	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Strykagen	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Strykagen	1	obfuscated obfuscation	National Institutes of Health	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Strykagen	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Strykagen	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Strykagen	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Strykagen	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Strykagen	1	obfuscated obfuscation	National Institutes of Health	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
National Institutes of Health	Yes	Grant - Strykagen	—
National Institutes of Health	Yes	Grant - Strykagen	—
National Institutes of Health	Yes	Grant - Strykagen	—
National Institutes of Health	Yes	Grant - Strykagen	—
National Institutes of Health	Yes	Grant - Strykagen	—